Monograph Details
|
|
Gastrointestinal Tract
> Hyperacidity, GERD, and ulcers
|
|
TAGAMET HB |
| Manufacturer |
|
GlaxoSmithKline Pharmaceuticals |
| Legal Classification |
|
OTC |
| Pharmacological Class |
|
H2 blocker. |
| Generic Name |
|
Cimetidine 200mg; tabs. |
| Also |
|
• TAGAMET HB SUSPENSION
|
| Indications |
|
Prevention and relief from heartburn, acid indigestion, and sour stomach. |
| Children |
|
Not recommended. |
| Adults |
|
Prevention: 200mg within ½ hour before eating/drinking. Relief: 200mg once daily as needed. Max 400mg/day. |
| Precautions |
|
Pregnancy. Nursing mothers. |
| Interactions |
|
May potentiate anticoagulants, phenytoin, theophylline, lidocaine, triazolam, and others by inhibition of hepatic microsomal enzymes. |
| How Supplied |
Tabs—6, 30, 50, 70
Susp—12oz (w. dose cup) |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
